He was accompanied by Telangana Governor C.P. Were also. Vice Chairman Radhakrishnan visited the company's premises in Genome Valley.
Dr. Krishna Ella, Executive Chairman, Bharat Biotech and Suchitra Ella, Co-Founder and Managing Director, Bharat Biotech welcomed the Vice President.
VP Dhankhar was briefed in detail about the manufacturing facility, the complex processes involved in vaccine production and the company's initiatives to develop new molecules and vaccine candidates to fight neglected diseases affecting developing countries, especially malaria. , focused on cholera, tuberculosis and. Chikungunya.
The Vice President, who began his tour by planting a medicinal plant, praised Bharat Biotech's dedication and resilience during unprecedented challenges.
He said, "I am at a place where people are driven by passion for research development and concern for society. Bharat Biotech has not only helped the country fight the pandemic by developing indigenous vaccines but also in digital penetration. Has contributed a lot." Supporting greater collaboration between industry, academia and more research across all sectors.
Dr. Krishna Ella thanked the Vice President for recognizing Bharat Biotech's dedication and reaffirmed the company's continued commitment to developing new vaccines, contributing to national self-reliance goals, and shaping a healthy future.
The Vice President was also taken on a virtual tour, which gave a glimpse of the inner workings of the production facility.
From state-of-the-art equipment to precise quality control measures, the virtual tour provided a fascinating insight into the meticulous process involved in the research and development of Rotavirus Vaccine, Typhoid Conjugate Vaccine and each vaccine dose coming out of the facility. , Hepatitis vaccine.
Dr. Krishna Ella, Executive Chairman, Bharat Biotech and Suchitra Ella, Co-Founder and Managing Director, Bharat Biotech welcomed the Vice President.
VP Dhankhar was briefed in detail about the manufacturing facility, the complex processes involved in vaccine production and the company's initiatives to develop new molecules and vaccine candidates to fight neglected diseases affecting developing countries, especially malaria. , focused on cholera, tuberculosis and. Chikungunya.
The Vice President, who began his tour by planting a medicinal plant, praised Bharat Biotech's dedication and resilience during unprecedented challenges.
He said, "I am at a place where people are driven by passion for research development and concern for society. Bharat Biotech has not only helped the country fight the pandemic by developing indigenous vaccines but also in digital penetration. Has contributed a lot." Supporting greater collaboration between industry, academia and more research across all sectors.
Dr. Krishna Ella thanked the Vice President for recognizing Bharat Biotech's dedication and reaffirmed the company's continued commitment to developing new vaccines, contributing to national self-reliance goals, and shaping a healthy future.
The Vice President was also taken on a virtual tour, which gave a glimpse of the inner workings of the production facility.
From state-of-the-art equipment to precise quality control measures, the virtual tour provided a fascinating insight into the meticulous process involved in the research and development of Rotavirus Vaccine, Typhoid Conjugate Vaccine and each vaccine dose coming out of the facility. , Hepatitis vaccine.
